Tajiri, K.; Hayashi, Y.; Murayama, A.; Muraishi, N.; Minemura, M.; Yasuda, I.
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection. Viruses 2025, 17, 44.
https://doi.org/10.3390/v17010044
AMA Style
Tajiri K, Hayashi Y, Murayama A, Muraishi N, Minemura M, Yasuda I.
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection. Viruses. 2025; 17(1):44.
https://doi.org/10.3390/v17010044
Chicago/Turabian Style
Tajiri, Kazuto, Yuka Hayashi, Aiko Murayama, Nozomu Muraishi, Masami Minemura, and Ichiro Yasuda.
2025. "Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection" Viruses 17, no. 1: 44.
https://doi.org/10.3390/v17010044
APA Style
Tajiri, K., Hayashi, Y., Murayama, A., Muraishi, N., Minemura, M., & Yasuda, I.
(2025). Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection. Viruses, 17(1), 44.
https://doi.org/10.3390/v17010044